TABLE 3.
Median survival of AML cells‐bearing NOD/SCID mice
| Kasumi‐1 cells‐bearing NOD‐SCID mice | ME‐1 cells‐bearing NOD‐SCID mice | ||
|---|---|---|---|
|
Median survival (Days) |
Median survival (Days) |
||
| Control | 15.5 | Control | 13.5 |
| VPA | 28.5 | NAB | 16 |
| Baicalein | 33.5 | Baicalein | 35 |
| #29 sample‐bearing NOD‐SCID mice | #39 sample‐bearing NOD‐SCID mice | ||
|---|---|---|---|
|
Median Survival (Days) |
Median Survival (Days) |
||
| Control | 14.5 | Control | 8.5 |
| VPA | 36.5 | VPA | 14.5 |
| Baicalein | 56.5 | Baicalein | 16 |